H&H International Investment’s Moderna MRNA Stock Holding History

H&H International Investment’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-83,000	Closed	-$2.35M	–	11
2025 Q1	$2.35M	Sell	83,000 -80,000	-49%	-$2.84M	0.02%	11
2024 Q4	$6.78M	Buy	163,000 +65,300	+67%	+$3.12M	0.05%	8
2024 Q3	$6.53M	Sell	97,700 -43,000	-31%	-$3.95M	0.04%	8
2024 Q2	$16.7M	Hold	140,700	–	–	0.1%	7
2024 Q1	$15M	Buy	140,700 +200	+0.1%	+$20.2K	0.11%	7
2023 Q4	$14M	Buy	140,500 +36,500	+35%	+$3.07M	0.1%	7
2023 Q3	$10.7M	Sell	104,000 -36,000	-26%	-$4.02M	0.08%	8
2023 Q2	$17M	Sell	140,000 -10,000	-7%	-$1.33M	0.12%	6
2023 Q1	$23M	Sell	150,000 -10,000	-6%	-$1.65M	0.17%	7
2022 Q4	$28.7M	Hold	160,000	–	–	0.27%	6
2022 Q3	$18.9M	Hold	160,000	–	–	0.2%	6
2022 Q2	$22.9M	Hold	160,000	–	–	0.27%	6
2022 Q1	$27.6M	Buy	160,000 +100,000	+167%	+$16.8M	0.29%	6
2021 Q4	$15.2M	Buy	+60,000	New	+$17.5M	0.19%	9

Other funds holding MRNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

H&H International Investment's MRNA Position: Q2 2025 in Review

H&H International Investment sold out of Moderna (MRNA) in Q2 2025, closing a stake of 83,000 shares — an estimated $2.35M sold.

H&H International Investment first reported a position in MRNA in Q4 2021 and held it in 14 quarters. The position peaked at $28.7M in Q4 2022. 675 funds tracked by Wall St. Rank hold MRNA as of Q2 2025.

H&H International Investment reported no remaining Moderna position as of Q2 2025 after selling out during the quarter.
H&H International Investment sold 83,000 Moderna shares in Q2 2025, an estimated $2.35M.
H&H International Investment first reported a position in Moderna in Q4 2021 and held it in 14 quarters.
H&H International Investment's Moderna position peaked at $28.7M in Q4 2022.
675 funds tracked by Wall St. Rank held Moderna as of Q2 2025.

Based on H&H International Investment's 13F filing for Q2 2025, filed 14 Aug 2025.